Detalhe da pesquisa
1.
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis.
Liver Int
; 44(2): 279-285, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100141
2.
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
Gastroenterol Hepatol
; 46(10): 764-773, 2023 Dec.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36731726
3.
Ertapenem neurotoxicity in liver transplantation.
Rev Esp Enferm Dig
; 114(4): 240-241, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933565
4.
Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation.
Liver Int
; 38(11): 1940-1950, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29660249
5.
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort.
J Hepatol
; 66(6): 1138-1148, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28189751
6.
Improved renal function in liver transplant recipients treated for hepatitis C virus with a sustained virological response and mild chronic kidney disease.
Liver Transpl
; 20(1): 25-34, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24115296
7.
[Strategies for avoiding hepatitis B infection recurrence following liver transplantation]. / Estrategias para evitar la recidiva viral B después del trasplante hepático.
Gastroenterol Hepatol
; 37 Suppl 2: 30-42, 2014 Jul.
Artigo
em Espanhol
| MEDLINE | ID: mdl-25087710
8.
Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.
Pharmacogenet Genomics
; 23(10): 509-17, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23873120
9.
Noninvasive Prediction of Outcomes in Autoimmune Hepatitis-Related Cirrhosis.
Hepatol Commun
; 6(6): 1392-1402, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989164
10.
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study.
Aliment Pharmacol Ther
; 56(1): 131-143, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470447
11.
One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease.
Aliment Pharmacol Ther
; 54(4): 462-469, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34181772
12.
[Medium-term management of protein-losing enteropathy of cardiac origin unresponsive to medical therapy in a patient awaiting heart transplantation]. / Manejo a medio plazo de la enteropatía pierde-proteínas de causa cardíaca, en un paciente que no responde al tratamiento médico, en espera de trasplante cardíaco.
Gastroenterol Hepatol
; 32(4): 279-82, 2009 Apr.
Artigo
em Espanhol
| MEDLINE | ID: mdl-19371966
13.
Effect of season and sunlight on viral kinetics during hepatitis C virus therapy.
BMJ Open Gastroenterol
; 4(1): e000115, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28321328
14.
Beyond cure: preventing and managing the complications of end-stage liver disease.
Curr Opin HIV AIDS
; 10(5): 355-60, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26248123
15.
Neurotoxicidad por ertapenem / Ertapenem neurotoxicity in liver transplantation
Rev. esp. enferm. dig
; 114(4): 240-241, abril 2022.
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-205613
16.
Manejo a medio plazo de la enteropatía pierde-proteínas de causa cardíaca, en un paciente que no responde al tratamiento médico, en espera de trasplante cardíaco / Medium-term management of protein - losing enteropathy of cardiac origin unresponsive to medical therapy inapatienta waiting heart transplantation
Gastroenterol. hepatol. (Ed. impr.)
; 32(4): 279-282, abr. 2009. ilus, graf
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-60793